This inventor holds 54 USPTO granted patents and 12 published patent applications, plus 7 CIPO patents and 11 EPO patents, primarily in Therapeutic Delivery Systems (CPC class C07D). Top assignees: Pharmain Corporation, Proteotech Inc., University of Washington. Active years: 2000-2026.
Inventors with similar research interests:
Location History:
- Seattle, WA (US) (2000 - 2010)
- Bothell, WA (US) (2007 - 2021)
Company Filing History:
17 out of 20 
14 out of 28 
14 out of 2,166 
Years Active: 2000-2026
Areas of Expertise:
Title: Gerardo M. Castillo: Innovator in Polymer Science and Therapeutic Development
Introduction
Gerardo M. Castillo, based in Bothell, WA, is a prolific inventor with a remarkable portfolio of 51 patents. His contributions primarily focus on the development of advanced polymer compositions for therapeutic applications. Castillo’s work has significant implications in the fields of medicine and drug delivery systems.
Latest Patents
Among his latest innovations is a patent titled "Method of production of graft co-polymer excipient with a superior peptide and protein binding property." This groundbreaking process involves preparing a semi-random graft co-polymer that enhances peptide stability and prolongs circulation time in biological systems when co-administered with peptides. Another notable patent by Castillo is the "Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same." This invention comprises a polymer backbone designed to deliver therapeutic agents effectively, targeting infections, inflammatory diseases, and tissue repair.
Career Highlights
Gerardo Castillo has made significant strides in his career, having worked with esteemed organizations such as Pharmain Corporation and the University of Washington. His experience in these institutions has provided him with a robust foundation in polymer science and drug development, further augmenting his inventive capabilities.
Collaborations
Throughout his career, Castillo has collaborated with distinguished colleagues, including Alan D. Snow and Beth P. Nguyen. These partnerships have enabled him to explore innovative ideas and push the boundaries of current therapeutic technologies.
Conclusion
Gerardo M. Castillo’s contributions to polymer science and therapeutic innovations are noteworthy and invaluable. His patents reflect a commitment to improving drug delivery methods, ultimately benefiting patient care and treatment effectiveness. As he continues to advance in his field, Castillo remains a key figure in the world of medical polymers and therapeutic development.